Advancing U.S. Bioeconomy through Partnership-Driven Regenerative Medicine Solutions.

This organization is a pivotal force in the biotechnical industry, specializing in the development and commercialization of regenerative medicine technologies. By leveraging its partnership-driven program, it is at the forefront of advancing U.S. bioeconomy objectives, including national security, health resilience, and economic growth. Its mission is to catalyze the scalable and cost-effective production of regenerative medicine technologies, transforming promising concepts into market-ready solutions. It fosters a collaborative environment, uniting over 170 members from industry, academia, and government to drive forward the capabilities of cell, tissue, and organ-based product manufacturing.

Serving as a bridge between the conceptual and commercial worlds of biotechnology, this entity provides extensive support across the entire product lifecycle. Offering full-service capabilities, from advanced biomanufacturing to securing intellectual property and navigating the regulatory landscape, the organization is instrumental in delivering innovative solutions to market. Its commitment to strengthening domestic supply chains and building a skilled workforce underscores its strategic importance in enhancing the global competitiveness of the bioeconomy. By affording members access to shared resources and collaborative opportunities, it ensures continuous innovation and adherence to U.S. health, economic, and national security priorities.